Springer Nature (SPG) Q2 2025 earnings summary

Executive summary

• Achieved strong H1 2025 performance with 6% underlying revenue growth and 10% adjusted operating profit growth, led by the Research segment and strategic focus on open access, AI, and digital innovation.

• Upward revision of full-year 2025 guidance for both revenue and adjusted operating profit, reflecting positive momentum and robust execution.

• Free cash flow improved by 51% to approximately €204 million, and financial leverage reduced to 1.9x.

• Continued investment in AI and technology, launching new tools and enhancing workflow efficiency.

Financial highlights

• Reported H1 2025 revenue reached €926 million; adjusted operating profit was €241 million.

• Adjusted EPS increased to €0.83 from €0.57 in H1 2024.

• Adjusted net income rose to €166 million, up €52.9 million year-over-year.

• Free cash flow improved to €204 million, up €69 million year-over-year.

• Financial leverage reduced to 1.9x, within the target range of 1.5x–2.0x.

Outlook and guidance

• Full-year 2025 revenue guidance raised to €1,930–1,960 million; adjusted operating profit forecast increased to €540–560 million, assuming stable macroeconomic and FX conditions.

• H2 2025 expected to be in line with H1, with continued strong performance in Research and stable contributions from Health and Education.

• Effective tax rate for 2025 expected to decrease to around 12% due to German tax legislation changes.